[1] |
SUN Yinghao, ZANG Shuangyao, YU Wenhui, GUO Shuai, LI Tingting, ZHANG Yi, ZHANG Tingjian, MENG Fanhao.
Effects and Challenges of Pharmacology and Toxicology of Aconitum Diterpenoid Alkaloids
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 601-607.
|
[2] |
BU Zixuan, XUE Mengwei, TIAN Jiawei, KE Kaile, WANG Ziying, LI Xiao, LU Tiangong.
Interventions of Guizhi Fuling Pills in Properties of Ovarian Cancer Stem Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 263-270.
|
[3] |
BAI Xue, CHEN Yafei, TANG Tian, LIU Zhejun, WANG Guoyu, TAN Tianyang.
Progress in Clinical and Pharmacological Research of Angong Niuhuang Pills
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 349-356.
|
[4] |
GAN Yena, HAN Sheng, YUAN Yi, XUE Lijuan, HUANG Haowen, LI Huanxin, ZHANG Xinci, KUI Siyi, MENG Bofei, LI Qifei, ANARGUL Tudi, LIU Zhifeng, QIN Lingling, LI Duoduo.
Possible Molecular Mechanisms of Dachengqi Decoction for Improving Subjective Symptoms of Degenerative Lumbar Spinal Stenosis: a Network Pharmacology Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 162-168.
|
[5] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
[6] |
ZHANG Kaihua, LIU Dingwei, FU Changhai, SUN Xuelin, MIN Xianjun.
Effects of rosastatin combined with Danggui Buxue Tang on expressions of AR and NR3C2
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 871-877.
|
[7] |
LI Xinlei, GONG Leilei, WANG Xiaoxia, ZHANG Xueyan, ZHAO Han, YAO Weijie, YUAN Sisi, FENG Xin.
Molecular mechanism of Yangxue Antai granules for the treatment of recurrent spontaneous abortion based on network pharmacology and molecular docking
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 366-370.
|
[8] |
RU Chen, HOU Xiujuan, QIAN Tangliang, DU Mengmeng, LI Yuan, LIU Xiaoping, ZHU Yuelan.
Compatibility and mechanism of a Chinese medicine compound in treating Sjogren's syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 397-403.
|
[9] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[10] |
CHEN Siyi, SHENG Lisong, SUN Rong.
Applications of “Target Fishing” Technique in Pharmacological Research of Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1321-1328.
|
[11] |
YIN Xiaoyang, ZHANG Xiaomeng, LIU Zeyu, LIU Yadi, WANG Yu, LIN Zhijian, ZHANG Bing.
Cardiotoxicity of Euodia rutaecarpa(Juss.) Benth. Based on Network Pharmacology and Untargeted Metabolomics
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1216-1223.
|
[12] |
BAI Xue, TAN Tianyang.
Research progress in reproductive and hepatorenal toxicological mechanisms of Tripterygium wilfordii
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1192-1199.
|
[13] |
BAI Zhaofang, ZHAN Xiaoyan, YAO Qing, CHEN Simin, ZHAO Xu, XIAO Xiaohe.
Theoretical innovation and technological breakthroughs in the safety evaluation of traditional Chinese medicine: disease-syndrome-based toxicology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 6-14.
|
[14] |
GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo.
Research progress on the animal models of idiosyncratic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39.
|
[15] |
ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan.
Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58.
|